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Association with the cellular coactivators p300 and CBP is required for the growth-regulatory function of adenoviral (Ad)
early region 1A (E1A) proteins. E1A regions necessary for these interactions overlap with domains involved in the induction
of tumours in immunocompetent rodents through highly oncogenic Ad12. Differences in the association of cellular factors
with the respective E1A domains of Ad12 and nononcogenic Ad2 might therefore be involved in serotype-specific oncoge-
nicity. We analyzed the interaction of the Ad12 E1A 235R protein with p300 and CBP. Here we demonstrate that in the case
of Ad12, but not Ad2/5, amino acids (aa) 1-29 of E1A proteins are sufficient to bind the p300–C/H3 domain in vivo and
wild-type p300 in vitro. The conserved arginine-2, which is essential for the interaction between Ad2 E1A and p300, was
dispensable for the Ad12 E1A 235R–p300 interaction in vitro. In addition to the p300–C/H3 region, we identified a second
domain within p300 (aa 1999-2200) binding to the 235R protein. Contrary to p300, the amino-terminus and CR1 are necessary
to associate with CBP. The aa 1-29 of the 235R protein but not CR1 are essential for the repression of colTRE-driven gene
expression. This repression function is strictly dependent on p300 but not on CBP. © 1999 Academic Press
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cINTRODUCTION
The adenoviral (Ad) early region 1 A (E1A) gives rise to
wo major proteins that are translated from a 13S and a
2S mRNA, respectively. These proteins are responsible
or most of the E1A gene-regulatory functions (reviewed
y Bayley and Mymryk, 1994; Rochette-Egly et al., 1990).
oreover they play a key role in the transformation
rocess mediated by E1A because they are essential for
he immortalization of primary cells (reviewed by Ber-
ards and van der Eb, 1984; Gallimore et al., 1985).
lthough all Ad serotypes are able to induce tumours in
mmunodeficient nude mice, only cells transformed by
ncogenic Ad serotypes (e.g., Ad12, Ad18, and Ad31)
roduce tumours in immunocompetent rodents (Williams
t al., 1995).
For nononcogenic Ad2/Ad5 E1A, the 13S and 12S mR-
As are translated in a 289R and a 243R protein, respec-
ively; for highly oncogenic Ad12 E1A, a 266R protein and
235R protein are generated (van Ormondt and Galibert,
984). The 289R and 266R proteins contain three regions
conserved region 1 (CR1), CR2, and CR3], which are
ighly conserved among Ad serotypes. They differ from
he 235R/243R proteins in that CR3 is removed due to
ifferential splicing. Most of the gene-regulatory func-
1 To whom reprint requests should be addressed. Fax: 49-201-723-
v974. E-mail: hyperlink to dieter.brockmann@uni-essen.de.
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94ions of the E1A oncoproteins are located in these con-
erved regions as well as in the nonconserved amino-
erminal domain [amino acids (aa) 1-29]. Of note, the
mino-terminus contains an arginine at position 2, which
s highly conserved among different Ad serotypes (Fig. 1;
imelman et al., 1985). Additionally, an ILE motif (single-
etter code) at position aa 18-20 (for Ad12 E1A) or aa
9-21 (for Ad2/Ad5 E1A) also shows homology, although
o a lesser extent (Kimelman et al., 1985).
Mutational analyses suggested that three regions are
rimarily responsible for the immortalizing and cell cycle-
egulating functions of Ad E1A: (1) the nonconserved
mino-terminus, (2) CR1, and (3) CR2 (reviewed by Bayley
nd Mymryk, 1994; Whyte et al., 1988). The E1A onco-
roteins induce G1/S transition by binding to cell cycle-
egulating cellular factors (reviewed by Bayley and Mym-
yk, 1994) like the coactivators p300 and CBP (CREB-
inding protein) (Dyson and Harlow, 1992) and the
ocket proteins (pRb, p107, and p130; Sidle et al., 1996).
he functional interaction of Ad2/Ad5 E1A with p300/CBP
s dependent on the amino-terminus and CR1 (Wang et
l., 1993a), whereas binding to the pocket proteins is
ediated by CR1 and/or CR2 (Barbeau et al., 1994; Howe
nd Bayley, 1992).
P300 and CBP belong to a class of transcriptional
oactivators that most probably serve as bridging factors
etween enhancer binding transcription factors and
omponents of the basal transcriptional machinery (re-
iewed by Janknecht and Hunter, 1996; Shikama et al.,
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95Ad12 E1A-p300/CBP PROTEIN COMPLEXES997). Moreover, they possess intrinsic histone acetyla-
ion function and therefore are able to modulate chroma-
in conformation (Ogryzko et al., 1996). P300 and CBP are
argeted by different classes of transcription factors like
TATs, AP-1, E2F/DP1, p53, and NF-kB to achieve tran-
criptional activation (reviewed by Avantaggiati et al.,
997; Merika et al., 1998; Shikama et al., 1997), thus
egulating differentiation, proliferation, and apoptosis
Kawasaki et al., 1998). In case of nononcogenic Ad2/
d5, p300 binding aa are mapped to the conserved Arg-2
f E1A proteins (Wang et al., 1993a). Additionally, the
is-3 and Leu-20 in the amino-terminal region and two
ubregions in CR1 (aa 30–49 and 68–85) contribute to
300 binding (Egan et al., 1988; Wang et al., 1993a).
owever, although it has been shown that both larger
1A proteins of highly oncogenic Ad12 associate with
300 and CBP in vivo (Dorsman et al., 1997; Wang et al.,
993b) little is known about the exact domains and aa
hat are involved.
The nonconserved amino-terminus (aa 1-29) and CR1
aa 39-79) of E1A are, besides the Ad12 E1A-specific
spacer” region (aa 124-143), involved in the oncogenicity
f Ad12 in immunocompetent rodents (Jelinek et al., 1994;
ereira et al., 1995; Telling and Williams, 1994). The
pacer region of Ad12 E1A, for example, gives rise to a
ighly oncogenic phenotype only in cooperation with
unction or functions located in the amino-terminus
nd/or CR1 (Jelinek et al., 1994). Moreover, using chi-
eric Ad12/Ad5 E1A genes, Pereira et al. (1995) have
hown that aa 1-42 of Ad12 E1A are involved in the
own-regulation of MHC class I gene expression, which
s described as one parameter of Ad12-mediated onco-
enicity (reviewed by Williams et al., 1995). Because both
omains, the amino-terminus and CR1, are also neces-
ary to bind p300, it is therefore important to characterize
ifferences in the associations of cellular factors like
300 with the amino-terminus and CR1 of E1A proteins
rom highly oncogenic Ad12 and from nononcogenic
d2/Ad5, which might help to provide some insight into
he process of oncogenic transformation. To compare
he in vivo interaction of Ad E1A proteins of different
erotypes with the cysteine/histidine-rich region 3 (C/H3)
f p300 (p300–C/H3), we made use of the recently de-
cribed yeast “SOS–two-hybrid” system (Aronheim et al.,
FIG. 1. Sequence comparison of the Ad12 E1A amino-terminus (aa
-29; single-letter code) with the Ad2 E1A amino-terminus. Conserved
a are boxed, aa with negatively or positively charged side chains (at
H 7) are indicated. A region with a predicted structural homology
a-helix motif; Gedrich et al., 1992) is overlined. Sequences originate
rom Van Ormondt and Galibert (1984).997). We found that the amino-terminus (aa 1-29) of ed12 E1A but not of Ad2/Ad5 E1A was sufficient to
ediate efficient binding to p300–C/H3 in vivo. GST pull-
own experiments detected (1) that full-length 235R
inds to at least two p300 domains (p300–C/H3 and the
ln-rich region located within aa 1999-2200) and (2) that
he amino-terminus is the most important interaction
otif. Interestingly, in the context of the 235R full-length
rotein, the Arg-2 was dispensable for physical interac-
ion. In contrast to p300, the amino-terminus on its own
as not sufficient to bind the p300 homolog CBP. More-
ver, cotransfected p300 counteracted 235R-mediated
epression of the phorbol ester responsive element of
he human collagenase promoter (colTRE), whereas CBP
id not. However, because the loss of repression func-
ion did not strictly correlate with the loss of interaction
ith p300, we conclude that other cellular factors also
re involved in the 235R-mediated colTRE repression.
RESULTS
he amino-terminus of Ad12 E1A is sufficient to bind
he p300–C/H3 domain
To identify domains in E1A proteins of the highly on-
ogenic Ad12 involved in the in vivo association with the
ellular coactivator p300, we made use of the recently
escribed yeast SOS–two-hybrid system in which pro-
ein–protein interactions are indicated by selective yeast
rowth of 36°C (Aronheim et al., 1997). A p300 mutant
panning the cysteine/histidine-rich domain 3 (p300–C/
3) was cloned into the myr-fusion protein expression
ector pYES2/myr and cotransfected with different SOS–
1A fusion protein expression vectors in yeast cdc25-2
ells which were tested then for growth under the selec-
ive temperature of 36°C. Interestingly, a fusion protein
ontaining aa 1-29 of Ad12 E1A (SOS–N12) strongly in-
eracted with p300–C/H3 (Fig. 2). In contrast, the respec-
ive SOS–N2 fusion showed no interaction (Fig. 2). Be-
ause it was described that for Ad2 E1A the amino-
erminus cooperates with CR1 to bind p300 (Wang et al.,
993a), we analyzed whether CR1 of Ad12 also is in-
olved in the in vivo binding to p300–C/H3. Both CR1 of
d12 E1A (SOS–CR1/Ad12; Fig. 2) and CR1 of Ad2 E1A
SOS–CR1/Ad2; Fig. 2), on their own, failed to bind to
300–C/H3. In contrast to this result, SOS–1-79/Ad12
containing the amino-terminus as well as CR1) and
OS–1-80/Ad2 bound to p300–C/H3 (Fig. 2). For SOS–1-
9/Ad12, however, yeast growth was reduced at the
elective temperature of 36°C in comparison with SOS–
12 (Fig. 2) for unknown reasons. These data confirm
hat the interaction of Ad2 E1A with p300 is mediated
ooperatively through the amino-terminus and CR1. In
ontrast to Ad2 E1A, the amino-terminus of Ad12 E1A (aa
–29), which is not conserved among different Ad sero-
ypes (Fig. 1; Kimelman et al., 1985), is sufficient for an
fficient binding to p300–C/H3.
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96 LIPINSKI ET AL.efinition of Ad12 E1A amino-terminal aa involved in
he binding to p300–C/H3
For Ad2 E1A, Arg-2, which is highly conserved among
denoviral serotypes, is essential for p300 interaction
Wang et al., 1993a). We therefore analyzed whether the
rg-2 in Ad12 E1A also is important for binding to this
ofactor. An amino-terminal (aa 1-29) Ad12 E1A point
utant in which the Arg-2 was changed to a glycine was
xpressed as SOS fusion (SOS–RG2/Ad12) and tested
ith p300–C/H3 in the yeast interaction assay. As shown
n Fig. 2, mutation of Arg-2 led to the loss of the p300–
/H3 binding capacity. The analyses of several other
d12 E1A amino-terminal point mutants revealed that
ro-7 (SOS–PA7/Ad12), Tyr-12 (SOS–YA12/Ad12), and
he-26 (SOS–FV26/Ad12) were not involved in p300–
FIG. 2. Binding of Ad12 and Ad2 E1A domains to the p300–C/H3 dom
pADNS/SOS) and myr-fusion (pYES2/myr) expression plasmids, plated
onditions of 25°C. Thereafter, four independent transformants were p
NB-(1)-galactose minimal plates, and then grown at the interaction s/H3 binding, as indicated by efficient yeast growth at a eelective temperature (Fig. 2). Mutation of Asp-16 led to
slightly reduced yeast growth (SOS–DA16/Ad12, Fig 2).
OS–LS19/Ad12 (mutation of Leu-19) was defective for
300–C/H3 interaction (Fig. 2). Interestingly, this Leu is
ocated within the partially conserved ILE consensus
otif (Kimelman et al., 1985). Because the respective aa
f Ad2 E1A (Leu-20; Wang et al., 1993a) is also necessary
or p300 binding, this result underscores the importance
f the ILE motif for the physical interaction with p300.
To exclude that the change of growth under selective
onditions of yeast transformed with SOS–E1A fusions
as not due to an inappropriate expression of the fusion
roteins, we checked their expression via binding to the
OS-interacting clone pYesM#7 (Aronheim et al., 1997).
hese experiments can be used to analyze fusion protein
east. cdc25-2 cells were cotransformed with the indicated SOS fusion
B-glucose minimal medium, and grown for 3 days under nonselective
grown at 25°C on YNB-glucose minimal medium, replica plated onto
e temperature of 36°C.ain in y
onto YN
icked,xpression because the SOS protein constitutes the car-
b
t
s
(
T
d
1
p
s
c
w
l
w
l
a
G
(
b
d
p
f
r
b
f
a
o
A
i
a
f
l
(
D
I
r
G
G
G
d
F
p
G
c
w
s
t
t
w
i
I
I
w
c
b
p
t
u
2
t
r
w
s
(
t
i
f
G
e
r
m
p
c
L
97Ad12 E1A-p300/CBP PROTEIN COMPLEXESoxyl-terminus of the fusion proteins. All SOS–E1A pro-
eins showed strong interaction with pYesM#7, demon-
trating the correct expression of the SOS–E1A fusions
data not shown).
he aa 1-29 of Ad12 E1A but not of Ad2 E1A pull-
own full-length p300 from HeLa-tk2 cell extracts
To examine whether the Ad12 E1A amino-terminus (aa
-29) is sufficient to interact with full-length p300, we
erformed GST pull-down assays using a GST-N12 fu-
ion protein containing aa 1-29 of Ad12 E1A and whole-
ell extract (WCE) prepared from HeLa-tk2 cells. P300
as detected by Western blotting. As shown in Fig. 3A,
ane 3, GST-N12 interacts efficiently with full-length p300,
hereas the GST leader sequence did not bind (Fig. 3A,
FIG. 3. Interaction mapping of the Ad12 E1A 235R protein with
ull-length p300 and CBP; 25 mg of affinity purified GST or indicated
ST-E1A fusions were incubated with 4 mg of HeLa-tk2 WCE. After
xtensive washing, bound proteins were analyzed on 6% SDS–polyac-
ylamide gels. Proteins were blotted onto Hybond-C extra nitrocellulose
embranes, and Western blot experiments were performed using a
300-specific polyclonal antiserum (A and B) or a CBP-specific poly-
lonal antiserum (C). The positions of p300 and CBP are indicated.
ane 1 represents 1% input of the HeLa-tk2 cell extract.ane 2), indicating that the interaction is due to the wdenoviral part of the fusion protein. On the other hand,
ST-N2 interacts only very slightly with full-length p300
Fig. 3A, lane 4). To exclude that the difference in the
inding capacities of GST-N12 and GST-N2 was due to
ifferent concentrations of both fusion proteins in GST
ull-down assays, conventional SDS–PAGE was per-
ormed with a constant aliquot of the glutathione Sepha-
ose bead-coupled GST-N12/N2 fusions. Coomassie
lue staining showed the comparable concentration of
usion proteins in this and all following GST pull-down
ssays (data not shown). These results confirm the data
btained in the yeast system indicating that aa 1-29 of
d12 E1A but not of Ad2 E1A are sufficient for an efficient
nteraction with p300.
Next, we extended our mutational analysis to identify
dditional aa in the Ad12 E1A amino-terminus necessary
or binding p300. The aa Pro-7 (GST-N12/PA7; Fig. 3A,
ane 6), Tyr-12 (GST-N12/YA12; Fig. 3A, lane 7), Asp-24
GST-N12/DA24; Fig. 3A, lane 12), and Glu-29 (GST-N12/
E29; Fig. 3A, lane 13) were not involved in p300 binding.
nterestingly, GST-N12/DA24 (Fig. 3A, lane 12) showed
eproducibly an increase in p300 binding compared with
ST-N12 (Fig. 3A, lane 3). On the other hand, the mutant
ST-N12/IP18 (Fig. 3A, lane 11) and the double-mutant
ST-N12/D2A216/17 (Fig. 3A, lane 8) were greatly re-
uced in their ability to interact with p300. As shown in
ig. 3A, lanes 9 and 10, Asp-16 was more important for
300 binding than Asp-17. Surprisingly, the point mutant
ST-N12/RG2 binds full-length p300 with the same effi-
iency as GST-N12 (Fig. 3A, compare lanes 3 and 5),
hich is in contrast to the results obtained in the yeast
ystem in which the p300–C/H3 domain was used. We
herefore conclude that p300 contains at least one addi-
ional domain outside C/H3 involved in the interaction
ith the Ad12 E1A amino-terminus. Of note, this physical
nteraction is independent of Arg-2 but depends on the
LE motif within the Ad12 E1A amino-terminus.
nteraction of the Ad12 E1A 235R full-length protein
ith p300 and CBP
To analyze the role of the amino-terminus within the
ontext of the Ad12 E1A 235R full-length protein in the
inding to p300, we generated several 235R deletion and
oint mutants as GST fusions and examined their ability
o interact with the coactivator in GST pull-down assays
sing HeLa-tk2 cell extract. As shown in Fig. 3B, GST-
35R efficiently bound to full-length p300 (lane 3). Dele-
ion of aa 1-29 geatly reduced the binding capacity of the
esultant mutant to p300 (GST-DN/235R; Fig. 3B, lane 4),
hereas a CR1 deletion mutant, GST-DCR1/235R, was
till able to bind p300, although binding was diminished
Fig. 3B, lane 5). These data suggest (1) that the amino-
erminus is the most important p300 interaction domain
n Ad12 E1A and (2) that CR1 is necessary to obtain 235Rild-type binding efficiency. GST-D1-79/235R, lacking
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98 LIPINSKI ET AL.oth the amino-terminus and CR1, showed no p300 bind-
ng activity (Fig. 3B, lane 6).
Compared with the GST-235R wild-type fusion, neither
he mutant GST-RG2/235R (mutation of Arg-2; Fig. 3B,
ane 7) nor the mutant GST-DA24/235R (mutation of Asp-
4; Fig. 3B, lane 11) was reduced in the ability to bind
ull-length p300, which is in agreement with the data
btained using a GST fusion protein containing exclu-
ively the Ad12 E1A amino-terminus (see also Fig. 3A).
nterestingly, GST-DA16/235R (mutation of Asp-16; Fig.
B, lane 8) also showed wild-type p300 binding activity,
hich is in contrast to the experiments using GST-N12/
A16 (Fig. 3A, lane 9). Latter fusion protein was reduced
n its capacity to interact with p300. This result suggests
hat CR1 might be able to compensate the defect of the
mino-terminus in GST-DA16/235R. Consistent with the
ata obtained using fusion proteins mutated in the ILE
otif (see Fig. 2 and Fig. 3A, lane 11), mutation of Ile-18
GST-IP18/235R; Fig. 3B, lane 9) or Leu-19 (GST-LS19/
35R; Fig. 3B, lane 10) in the 235R full-length protein led
o a reduction in p300 binding, again underscoring the
mportance of this motif for the binding to p300.
Because p300 is highly related to the coactivator CBP
Shikama et al., 1997), we checked the interaction of the
d12 E1A 235R protein with CBP. The respective GST
ull-down assays followed by Western-blotting using an
nti-CBP-specific antibody revealed a similar interaction
attern as for p300 (Fig. 3C). However, the association
35R/CBP is completely prevented through the deletion
f the E1A amino-terminus (GST-DN/235R; Fig. 3C, lane
) and nearly abolished through removal of CR1 (GST-
CR1/235R; Fig 3C, lane 5). Together with our finding
hat the amino-terminus on its own is unable to physi-
ally interact with CBP (data not shown), we conclude
hat the 235R protein of Ad12 E1A interacts with CBP
ooperatively through the amino-terminus and CR1,
hich is in contrast to its interaction with p300. As for
300, an intact ILE motif is decisive for the binding of
35R to CBP because the mutation of either Ile-18 (GST-
P18/235R; Fig. 3C, lane 9) or Leu-19 (GST-LS19/235R;
ig. 3C, lane 10) prevented complex formation.
d12 E1A binds at least two p300 domains
It was suggested by Kurokawa et al. (1998) that Ad2
1A proteins interact with at least three different do-
ains in p300/CBP with a comparable affinity: (1) aa
-450, (2) aa 1459-1891 (spanning C/H3), and (3) aa
058-2163 (containing a Gln-rich region). Because Ad12
1A and Ad2/Ad5 E1A showed different binding proper-
ies with respect to p300, we wanted to know whether
he 235R protein interacts with these p300 domains as
ell. We therefore transcribed/translated three p300
ragments in vitro (aa 1-450, 1519-1850, and 1999-2200)
nd analyzed their binding capacity to the 235R protein in
ST pull-down assays. As expected, the C/H3-containing pragment (aa 1519-1850) strongly interacted with GST-
35R (Figs. 4A, lane 12, and 4B, lane 4). Furthermore, the
35R protein is bound by aa 1999-2200 of p300 (Figs. 4A,
ane 11, and 4C, lane 4). On the other hand, an associa-
ion with aa 1-450 of p300 was hard to detect (Fig. 4A,
ane 13). Interestingly, the 243R protein of Ad2 E1A
howed an Ad12 E1A-comparable interaction pattern
ith the p300 fragments. Ad2 E1A interacted strongly
ith the C/H3-containing polypeptide (aa 1519-1850; Fig.
A, lane 9) and with aa 1999-2200 (Fig. 4A, lane 8). As in
ase of the 235R protein, an association with aa 1-450 of
300 was hardly detectable (Fig. 4A, lane 10). The latter
esult is in contrast to data obtained by Kurokawa et al.
1998) indicating that Ad2 E1A interacts with all three
300 domains with a similar affinity. The reason for these
ifferent results is not yet clear but might be due to
ifferent assay conditions. For example, Kurokawa and
oworkers incubated GST-p300 fusion proteins with in
itro translated Ad2 E1A, whereas we used GST-Ad12
1A and GST-Ad2 E1A fusion proteins in combination
ith in vitro translated p300 polypeptides.
To analyze whether the 235R protein interacts with
300–C/H3 and the p300 Gln-rich region (aa 1999-2200)
sing different or overlapping domains, GST pull-down
ssays were performed with the Ad12 E1A mutants de-
cribed in Fig. 3 and the respective in vitro translated
egions of p300. The results using the p300–C/H3 mutant
orrelate well with the data obtained in the GST pull-
own assays using HeLa-tk2 cell extracts (compare Fig.
B with Fig. 3B). Binding was mediated predominantly by
he amino-terminus, although CR1 was involved, too, in
he full-length 235R context (Fig. 4B, lanes 5 and 6).
nexpectedly, the mutant GST-D1-79/235R, which
howed no detectable interaction with full-length p300
rom HeLa-tk2 extracts (Fig. 3B), gave rise to a weak
ssociation with p300–C/H3 (Fig. 4B, lane 7). The reason
or this discrepancy is not yet clear, but it is most prob-
bly due to an nonspecific interaction of the mutated
35R protein and the C/H3 domain. As expected, muta-
ion of Arg-2, Asp-16, and Asp-24 did not interfere with
inding to p300–C/H3 (Fig. 4B, lanes 8, 9, and 12),
hereas the mutants GST-IP18/235R and GST-LS19/
35R showed a strongly reduced binding capacity (Fig.
B, lanes 10 and 11).
Next, we tested the p300 fragment aa 1999-2200, span-
ing the Gln-rich region, for its interaction with the 235R
rotein. In contrast to the p300–C/H3 domain, the mutant
ST-DN/235R lacking aa 1-29 failed to bind aa 1999-2200 of
300 (Fig. 4C, lane 5). Moreover, deletion of CR1 strongly
educes the interaction potential of the resultant mutant
GST-DCR1/235R; Fig. 4C, lane 6). These data suggest a
ooperativity in the binding to aa 1999-2200. Consequently,
he mutant GST-D1-79/235R, lacking both the amino-termi-
us and CR1, was defective, too, for binding aa 1999-2200 of
300 (Fig. 4C, lane 7). As shown for the C/H3 spanning
olypeptide (Fig. 4B), the 235R point mutants Arg-2, Asp-16,
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99Ad12 E1A-p300/CBP PROTEIN COMPLEXESnd Asp-24 were not decreased in binding (Fig. 4C, lanes 8,
, and 12), whereas the point mutants Ile-18 and Leu-19
ere defective for binding to aa 1999-2200 of p300 (Fig. 4C,
anes 10 and 11), indicating that both p300 regions were
ound by overlapping, if not identical, 235R protein do-
ains.
epression of the colTRE by the Ad12 E1A 235R
rotein is counteracted by overexpressed p300
ut not CBP
E1A proteins repress the human collagenase pro-
oter (van Dam et al., 1989, 1990) via the collagenase
PA response element (colTRE; Offringa et al., 1990). The
olTRE is bound by the transcription factor complex AP-1
Angel et al., 1987), which recruits p300/CBP as coacti-
ators to the promoter (Arias et al., 1994). Therefore, we
nalyzed whether the 235R protein represses colTRE-
riven gene expression in a p300-, and/or CBP-, depen-
ent manner. Cotransfection of a 3xcolTREtk-CAT re-
FIG. 4. The Ad12 E1A 235R protein binds to the p300–C/H3 domain and t
ragments (aa 1-450, 1519-1850, or 1999-2200) were incubated with either
ST leader sequence and the 243R protein of Ad2 E1A (GST-243R; lanes
rotein of Ad12 E1A (GST-235R; lanes 11–13). Bound material was analyz
epresent 10% input of the respective p300 mutant, and lane 1 shows the
nd C) 35S-Labeled, in vitro translated p300 fragments (aa 1519-1850, B; aa
usion proteins consisting of the GST leader sequence and the 235R mutorter construct with a 235R expression vector in HeLa- ak2 cells resulted in a strong repression of CAT gene
xpression (;10-fold; Fig. 5A). An additional cotransfec-
ion of an increasing amount of a p300 expression vector
pCMVb-p300) counteracted the repression, whereby co-
ransfection of .0.2 mg pCMVb-p300 resulted in a strong
ranscriptional squelching effect. Most interestingly, co-
ransfection of a CBP expression vector (pRc/RSV-CBP)
id not restore 235R-repressed promoter activity (Fig.
B). To exclude that the inability of CBP to restore 235R-
epressed CAT gene expression from 3xcolTREtk-CAT is
ue to an insufficient expression of the coactivator, we
otransfected pRc/RSV-CBP with a protein kinase A ex-
ression vector (RSV-CHO-PKAca) and the reporter
2Ad12-(140bp)-CAT in HeLa-tk
2 cells. E2Ad12-(140bp)-
AT contains 140 bp of the Ad12 E2e promoter, which is
ctivated through ATF-1 and CREB-1 transcription factors
n response to PKA (P. Fax, H. Esche, and D. Brockmann,
npublished data). Specific phosphorylation of ATF-1 and
REB-1 through PKA enables their interaction with CBP,
00 Gln-rich region (aa 1999-2200). (A) 35S-Labeled, in vitro translated p300
tein leader sequence GST (lanes 5–7), a fusion protein consisting of the
or a fusion protein consisting of the GST leader sequence and the 235R
12% SDS–polyacrylamide gel and detected by fluorography. Lanes 2–4
lar weight marker (sizes of marker proteins are indicated on the left). (B
200, C) were incubated with the protein leader sequence GST (lane 3) or
indicated (lanes 4–12).o the p3
the pro
8–10),
ed on a
molecu
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100 LIPINSKI ET AL.iewed by Montminy, 1997). As shown in Fig. 5C, cotrans-
ection of E2Ad12-(140bp)-CAT with RSV-CHO-PKAca
eads to a slight increase in CAT gene expression. The
ddition of increasing amounts of pRc/RSV-CBP results
FIG. 5. 235R-mediated repression of the collagenase TRE is coun-
eracted by p300 but not by CBP. HeLa-tk2 cells were cotransfected
ith a human collagenase TRE-driven reporter plasmid (3xcolTREtk-
AT: 0.2 mg), a 235R expression plasmid (0.5 mg), and increasing
mounts of a p300 (A) or a CBP (B) expression plasmid (20 pg to 4 mg).
AT activity was determined 40 h after transfection. Three independent
xperiments were performed. CAT activity in the presence of pRc/RSV
as set at 100%. (C) CBP transactivates the Ad12 E2e promoter in the
resence of PKA. HeLa-tk2 cells were cotransfected with a reporter
lasmid driven by the Ad12 E2e promoter (1 mg; E2Ad12-(140bp)-CAT)
nd a CBP expression plasmid (500 pg to 1 mg; pRc/RSV-CBP) in the
resence or absence of a PKA expression plasmid (100 ng; RSV-CHO-
KAca). CAT activity was determined 40 h after transfection. CATtctivity in the presence of pRc/RSV was set at 1.n a further induction of reporter gene expression up to
.5-fold (compared with basal reporter activity), which is
n the activation range observed cotransfecting CBP/
300 expression vectors with other reporter constructs
see, for example, Gerritsen et al., 1997; Marzio et al.,
998). As expected, cotransfection of pRc/RSV-CBP with
2Ad12-(140bp)-CAT in the absence of exogenous PKA
id not lead to CAT gene activation (Fig. 5C), most prob-
bly due to an insufficient amount of phosphorylated
TF-1/CREB-1. These data indicate that CBP is ex-
ressed from pRc/RSV-CBP and that p300 and CBP are
unctionally not homologs with respect to the activation
f the colTRE element.
To examine whether the amino-terminus and/or CR1 is
nvolved in the 235R-mediated repression of the colTRE-
riven reporter gene expression, we cotransfected re-
pective mutants with the 3xcolTREtk-CAT reporter in
eLa-tk2 cells. Compared with the 235R wild-type pro-
ein, the repression activity of DN/235R was ;50% re-
uced (Fig. 6A), indicating that the amino-terminal do-
ain, which was sufficient to mediate a 235R/p300 in-
FIG. 6. The repression of colTRE-driven reporter gene expression by
he 235R protein is dependent on the amino-terminus but not on CR1.
eLa-tk2 cells were cotransfected with a human collagenase TRE-
riven reporter plasmid (3xcolTREtk-CAT: 0.2 mg) and a 235R wild-type
r 235R deletion mutant expression plasmids (A; 0.5 mg) or 235R point
utant expression plasmids (B; 0.5 mg) as indicated. CAT activity was
etermined 40 h after transfection. Three independent experiments
ere performed. CAT activity in the presence of pRc/RSV was set at
00%.eraction, is important for this repression function. In
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101Ad12 E1A-p300/CBP PROTEIN COMPLEXESontrast to DN/235R, the mutant DCR1/235R repressed
xcolTREtk-CAT with wild-type efficiency (Fig. 6A). These
ata suggest that down-regulation of colTRE-dependent
ene expression is mediated by different domains of the
35R Ad12 E1A and 243R Ad2 E1A protein. In the latter
ase, CR1 was shown to be essential (Dorsman et al.,
995; Hagmeyer et al., 1993; Offringa et al., 1990). Sur-
risingly, the mutant D1-79/235R lacking the amino-ter-
inus and CR1 contains a repression function compa-
able to DN/235R (Fig. 6A), although it is completely
efective in p300 binding. Because Western blot analy-
es using an Ad12-E1A specific antiserum indicated that
ifferences in the repression capacity of the 235R mu-
ants did not correlate with differences in their concen-
rations in transient transfected cells (Fig. 7), we draw the
onclusion that the residual repression is most probably
ue to a p300-independent mechanism.
To analyze whether the loss of binding to p300 corre-
ates with a loss of repression function of the 235R
rotein, we tested 235R amino-terminal point mutants
egarding their ability to repress CAT gene expression
rom 3xcolTREtk-CAT. Surprisingly, only the Arg-2 point
utant (RG2/235R) showed a significant decrease in
epression function (;50% compared with the 235R wild-
ype protein; Fig. 6B). All other point mutants tested
DA16/235R, IP18/235R, LS19/235R, DA24/235R, and
V26/235R) were still able to repress the colTRE-driven
AT gene expression (Fig. 6B). Western blot experiments
emonstrated a comparable expression of the 235R
oint mutants in transiently transfected cells (Fig. 7, com-
are lanes 8–13). These data show that there is no strict
FIG. 7. Expression analyses of the 235R wild-type and 235R mutant
roteins in transiently transfected COS7 cells; 1 3 106 COS7 cells were
eeded and transiently transfected with a 235R wild-type (lane 4) or
35R mutant expression plasmids (lanes 5–13) as indicated. For West-
rn blot analysis, 80 mg of nuclear extracts were separated by SDS–
AGE and blotted onto Hybond-C extra nitrocellulose membranes.
etection of E1A proteins were performed using a polyclonal sheep
nti-Ad12 E1A antiserum. The arrowheads indicate the positions of the
espective E1A proteins. Lane 1 shows molecular weight marker (in-
icated sizes on the left); lane 2, control extract: nuclear extract pre-
ared from Ad12 E1-transformed human endothelial kidney cells (HEK;
hittaker et al., 1983); and lane 3, mock-transfected COS7 cells.orrelation between loss of 235R/p300 binding and the doss of 235R repression function. We therefore conclude
hat either more than one contact point between the
35R protein and p300 is needed for disruption of AP-1–
300 complexes or that other cellular factors are in-
olved in the activation of the colTRE that also are re-
ressed by the 235R protein.
DISCUSSION
The nonconserved amino-terminus plays an important
ole in the immortalization function of E1A by binding to
ellular coactivators like p300 and CBP (Smits et al., 1996).
oreover, the colocalization of several distinct cellular fac-
ors within the same E1A molecule might be important to
ediate immortalization and specific gene-regulatory func-
ions (reviewed by Bayley and Mymryk, 1994; Wang et al.,
995). Due to these results, it is reasonable to assume that
1A of highly oncogenic and nononcogenic Ads might
ssemble with cellular factors to different multiprotein com-
lexes that might be responsible for their different onco-
enic behaviour. We therefore compared the association of
300 and CBP with E1A proteins of highly oncogenic Ad12
nd nononcogenic Ad2.
The interaction between E1A of nononcogenic Ad2/
d5 and p300 is well characterized. Wang and cowork-
rs have shown that at least three amino-terminal resi-
ues within Ad5 E1A are important for p300 binding:
rg-2, His-3 and Leu-20. Their mutation leads either to a
otal loss (Arg-2) or strong reduction (His-3, Leu-20) of
d5 E1A/p300 association. In addition, two regions in
R1 were identified to be involved in p300 binding: aa
0-49 and aa 70-81 (Egan et al., 1988; Wang et al., 1993a).
ost importantly, these data demonstrate that the ami-
o-terminus and CR1 of Ad2/Ad5 E1A have to cooperate
o bind p300. Neither domain alone is able to interact
hysically with p300 or CBP. Contrary to these findings,
e could show that the amino-terminus of Ad12 E1A (aa
-29) is sufficient to bind the C/H3 domain of p300.
owever, we cannot exclude that these different interac-
ion profiles might be partly attributed to the different
ssay systems used. We obtained our results using the
east SOS–two-hybrid system and GST pull-down as-
ays, but Egan et al. (1988) and Wang et al. (1993a)
erformed coprecipitation experiments of Ad5-infected
B cells or monoclonal antibody competition assays us-
ng extracts of infected HeLa cells.
We have identified two aa that are involved in the
ssociation of p300 with the 235R full-length protein.
oth are located in the ILE motif (Ile-18 and Leu-19).
sing the yeast SOS–two-hybrid system with the amino-
erminus and p300–C/H3, we identified a third interacting
1A aa: Arg-2. Surprisingly, this aa is not important to
ind p300 in GST pull-down assays. Because Arg-2 is
lso essential for 235R-mediated repression of colTRE-
riven gene expression, these data might reflect differ-
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102 LIPINSKI ET AL.nces in aa necessary for physical and functional inter-
ctions.
Our finding that the amino-terminus of Ad12 E1A is the
ain interaction motif for p300 is in contrast to results of
awada et al. (1997), suggesting that the amino-terminus
f Ad12 E1A proteins (aa 1-30) on its own is not able to
ind p300 and that CR1 is the most important interaction
omain. These authors obtained their results in GST
ull-down experiments with GST-E1A mutants and 35S-
abeled cell extracts of different cell lines but without a
irect proof for p300 like, for example, Western blot
xperiments with an anti-p300-specific antiserum.
In addition to the p300–C/H3 domain, the 235R protein
f Ad12 E1A interacts with a second p300 fragment
panning the Gln-rich region (aa 1999-2200). In contrast
o the binding to the C/H3 domain, latter interaction is
ependent on a cooperation of the amino-terminus with
R1. Moreover, this interaction is strictly dependent on
he ILE motif but independent of the conserved Arg-2
nder these in vitro conditions. Our mutational analyses
lso revealed that both p300 fragments interact with the
ame domains and aa in the 235R protein. Both frag-
ents were bound by the amino-terminus and CR1 and
n both cases the interaction is dependent on Ile-18 and
eu-19. Arg-2, Asp-16, and Asp-24 are not involved under
n vitro conditions. However, we cannot rule out the
ecessity of up-to-now-unidentified aa that are possibly
pecific for the interaction with one or the other p300
ragment. Taken together, these data suggest that Ad12
nd Ad2/Ad5 E1A proteins might use at least partially
ifferent aa to interact with the coactivator p300, which
ight result in the generation of serotype-specific p300/
BP containing E1A multiprotein complexes.
We also analyzed the interaction of the 235R protein
ith the p300 homolog CBP. In contrast to p300, the
inding of the 235R protein to CBP is strictly dependent
n the cooperation between the amino-terminus and
R1. This association is independent of Arg-2 but depen-
ent on Ile-18 and Leu-19. These data suggest that al-
hough identical or overlapping domains are necessary
or the association between 235R and p300 or CBP, the
echanism of complex formation is different. In case of
300, the amino-terminus is sufficient to bind to p300,
hereas in case of CBP, the amino-terminus has to
ooperate with CR1 for an efficient association.
E1A represses the transactivating activity of transcrip-
ion factor AP-1, which binds to the collagenase TRE
romoter element (Angel et al., 1987; Offringa et al.,
990). Because it is known that AP-1 uses p300/CBP as
oactivators (Arias et al., 1994), we asked whether p300
nd/or CBP can counteract the 235R-mediated repres-
ion of colTRE-driven gene expression. Interestingly, the
35R-dependent repression of CAT gene expression
rom 3xcolTREtk-CAT can be restored by cotransfected
300 but not by CBP in transient expression assays,
uggesting that p300 and CBP are not functional ho- cologs on this promoter. These data fit in with the notion
hat both coactivators have at least partially different
unctions (Kawasaki et al., 1998; Yao et al., 1998). On the
ther hand, it is not yet clear whether CBP is able to
ounteract the repression of the colTRE-driven gene ex-
ression mediated by the 243R protein of nononcogenic
d2/Ad5 E1A. Data published by Lee et al. (1996) have
hown that only p300, not CBP, was able to relieve the
d2/Ad5 E1A 243R-mediated repression in transiently
ransfected HeLa cells, whereas Smits et al. (1996) were
ble to rescue 243R-mediated colTRE repression in
eLa cells by cotransfected p300 and CBP.
For Ad12 E1A, the amino-terminus is the decisive do-
ain for the 235R-mediated colTRE repression. The de-
etion of CR1 does not impair the repression activity. This
s an interesting finding because repression mediated by
d2/Ad5 E1A depends on both, CR1 and the amino-
erminus (Dorsman et al., 1995; Hagmeyer et al., 1993;
ffringa et al., 1990). Surprisingly the mutant D1-79/235R
f Ad12 E1A lacking the amino-terminus as well as CR1
howed also repression function, indicating either a re-
idual p300-binding capacity not detectable in Western
lots but hardly detectable in GST pull-down assays or
n additional p300-independent repression mechanism.
he latter assumption is supported by the finding that
here was no strict correlation between aa responsible
or physical interaction with p300 and those responsible
or 235R-mediated colTRE repression function. For ex-
mple, the mutant RG2/235R of Ad12 E1A, which binds
300 comparable to 235R wild-type in GST pull-down
ssays, showed a decreased repression function com-
arable to that of the mutants DN/235R and D1-79/235R.
n addition to our assumption that there might be differ-
nces in aa needed for physical and functional interac-
ions, these data indicate that other cellular factors as
ell might be involved in the regulation of the colTRE that
lso are repressed by Ad12 E1A. This hypothesis is
onsistent with the finding of Wang et al. (1993a) indicat-
ng that the 243R point mutant LS20, which was strongly
educed in p300 binding, showed a wild-type 243R en-
ancer repression function.
In conclusion, our data suggest that p300 binds differ-
ntly to the 235R protein of Ad12 E1A and to the 243R
rotein of Ad2/Ad5 E1A. This might allow the generation
f different multiprotein complexes that might contribute
o a serotype-specific regulation of the expression of
pecific genes and/or to the different oncogenic poten-
ials of Ad12 and Ad2/Ad5.
MATERIALS AND METHODS
lasmids
The cDNA for the Ad12 235R wild-type protein and the
eporter construct 3xcolTRE-tk-CAT were described else-
here (Brockmann et al., 1990, 1994). E2Ad12-(140bp)-CATontains a 140-bp fragment of the Ad12 E2e promoter
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103Ad12 E1A-p300/CBP PROTEIN COMPLEXESncluding the ATF-1/CREB-1 binding site and the TATA-
ox in the basal CAT reporter construct pBL-CAT3
Luckow and Schu¨tz, 1987; P. Fax, H. Esche, and D.
rockmann, unpublished data). The cDNA for the Ad2
43R wild-type protein was a generous gift of W. Doerfler
Institute of Genetics, University of Cologne, Cologne,
ermany). pCMVb-p300 (Eckner et al., 1994) and pRc/
SV-CBP (Kwok et al., 1994) were obtained from A. van
er Eb (Department of Medical Biochemistry, Leiden
niversity, The Netherlands).
DN/235R (lacking aa 1-29 of the 235R wild-type pro-
ein), DCR1/235R (lacking the conserved region 1 [aa
0-79] of the 235R wild-type protein), and D1-79/235R
lacking aa 1-79 of the 235R wild-type protein) were
enerated by cloning the respective coding regions of
d12 E1A, generated by PCR, into the HindIII site of the
ukaryotic expression vector pRc/RSV (Invitrogen). Like-
ise, RG2/235R, DA16/235R, IP18/235R, LS19/235R,
A24/235R, and FV26/235R contain cDNAs cloned into
Rc/RSV coding for Ad12 E1A 235R mutants with indi-
ated single aa exchanges (aa are given in the single-
etter code and the number represents the position of the
espective aa in the 235R wild-type protein; for example,
n the RG2/235R mutant, the arginine at posisiton 2 is
eplaced by a glycine). The mutations were generated by
CR using respective point-mutated 59-oligonucleotides.
The GST-E1A fusions were constructed by cloning the
espective coding regions of Ad12 or Ad2 E1A cDNAs/
utants (as described above) into the BamHI site of the
ST-fusion expression vector pGEX-2T (Pharmacia).
The pYES2 plasmid (Invitrogen) containing the v-Src
yristoylation signal (pYES2/myr) and the pADNS plas-
id (Colicelli et al., 1989) containing the human SOS
rotein (pADNS/SOS) were described elsewhere (Aron-
eim et al., 1997). Myr-C/H3 was generated by cloning
he coding region for aa 1572–1818 of p300 into the SmaI
ite of pYES2/myr. All SOS fusions were generated by
loning the indicated E1A coding regions of Ad2 or Ad12
nto the SmaI site of pADNS/SOS. Cloning leads to a
usion protein with adenoviral sequences as the amino-
erminus and SOS as the carboxyl-terminus.
pcDNA3.1-p300/1-450 codes for aa 1-450 of p300,
cDNA3.1-p300/1519-1850 codes for aa 1519-1850 of
300, and pcDNA3.1-p300/1999-2200 codes for aa 1999-
200 of p300. These mutants were obtained by cloning
he respective p300 PCR fragments in the EcoRI/BamHI
ites of the pcDNA3.1A expression vector (Invitrogen).
The sequence of all fusion genes and mutants was
onfirmed by sequencing using an automated laser flu-
rescent DNA sequencer (Pharmacia).
ell culture
HeLa-tk2 and COS7 cells were grown in Dulbecco’s
odified Eagle’s medium supplemented with 10% fetalalf serum in 6% CO2. Treparation of WCEs
HeLa-tk2 cells were seeded onto 14.5-cm cell culture
ishes, and cells were grown to near-confluence for 2–3
ays. Cells were trypsinated, washed with PBS2/2 (lack-
ng Mg11 and Ca11), and lysed in WCE lysis buffer (50
M Tris–Cl, pH 8.0, 150 mM NaCl, 0.1% Triton X-100, 5
M EDTA, pH 8.0, 20 mM NaF, 1 mM DTT, 1 mM Na3VO4)
upplemented with freshly added protease inhibitors (10
g/ml aprotinin, 10 mg/ml leupeptin, and 0.2 mM PMSF)
y incubation on a rotating shaker at 4°C for 40 min.
rude lysates were then cleared by centrifugation at
2,000g and 4°C for 10 min. WCE was precleared two
imes with 150 ml of glutathione–Sepharose beads.
hereafter, the protein concentration was determined by
he Bradford method (Bradford, 1976), and extracts were
rozen at 280°C until use.
The preparation of nuclear extracts was performed as
escribed by Schreiber et al. (1989).
n vitro transcription/translation and GST pull-down
ssays
The GST leader protein and GST fusion proteins were
urified from the soluble fraction of Escherichia coli bac-
eria as described earlier (Brockmann et al., 1995). Then,
5-50 mg of GST fusion proteins coupled to glutathione–
epharose beads were incubated with 4-5 mg of WCE
nder gently shaking for 1 h at 4°C. Alternatively, incu-
ation was performed with 100,000 cpm of in vitro tran-
cribed/translated p300 fragments in WCE buffer. There-
fter, glutathione–Sepharose beads were washed three
imes with 1 ml of WCE lysis buffer. For analysis of bound
roteins, the beads were boiled for 5 min in 13
aemmli’s buffer and loaded onto 6% or 12% SDS–poly-
crylamide gels (Laemmli, 1970).
For in vitro transcription/translation, the TNT T7 Quick
oupled Transcription/Translation System (Promega)
as used according to the manufacturer9s instructions.
estern blot analyses
Immunoblot analyses were performed as described
lsewhere (Harlow and Lane, 1988). Proteins separated
n SDS–polyacrylamide gels were blotted onto nitrocel-
ulose membranes (Schleicher & Schuell) for 85 min at
.7 mA/cm2 in transfer buffer (48 mM Tris, 39 mM glycine,
.8% SDS, and 20% methanol). The membrane was then
locked in TBS-T/10% milk powder (10 mM Tris, pH 8.0,
50 mM NaCl, 0.1% Tween 20) for 1 h at room tempera-
ure. Thereafter, the membrane was incubated with the
rimary antibody [polyclonal anti-p300 (C-20, Santa
ruz): 1 mg/ml; polyclonal anti-CBP (A-22, Santa Cruz): 1
g/ml; polyclonal sheep anti-Ad12 E1A antiserum: 1:5000
iluted; a generous gift of P. H. Gallimore, CRC Institute
or Cancer Studies, Edgbaston, Birmingham, UK] in TBS-
/10% milk powder for 1 h at room temperature. After
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104 LIPINSKI ET AL.xtensive washing, the membrane was incubated with
he secondary antibody [anti-rabbit IgG horseradish per-
xidase (Amersham): 1:10,000; anti-sheep IgG horserad-
sh peroxidase (Pierce): 1:150,000) in TBS-T/0.5% milk
owder for 30 min at room temperature. After extensive
ashing, enhanced chemiluminescence was carried out
sing the ECL Western blotting detection system (Pierce)
s described by the manufacturer.
AT assays
For transient expression assays, 2.5 3 105 HeLa-tk2
ells were seeded. After 24 h, cells were cotransfected
y the Lipofectamine method (Felgner and Ringold, 1989)
ith 0.2 mg of 3xcolTREtk-CAT reporter construct and
arying amounts of the respective expression vectors as
ndicated in the figure legends. At 40 h after transfection,
CEs were prepared by the freeze-and-thaw procedure.
he protein concentration of the extracts was deter-
ined using the Bradford method (Bradford, 1976). Equal
mounts of protein was used to determine CAT enzyme
ctivity as described (Gorman et al., 1982). CAT activity
as quantified using an automatic TLC-linear analyzer
Berthold, Bad Wildbad, Germany).
east SOS–two-hybrid experiments
The preparation of competent cdc25–2 cells (Aron-
eim et al., 1997) and their transfection were performed
ccording to the lithium acetate protocol of Klebe et al.
1983) with a minor modification (growth temperature:
5°C). For cotransfection, 1 mg of each yeast expression
lasmid (pYES2/myr and pADNS/SOS) was used. After
ransfection, cdc25-2 cells were plated onto YNB-
lucose minimal medium [containing 2% glucose, 0.5%
NH4)2SO4, 0.17% yeast-nitrogen-base (YNB), 3% agar,
nd 0.068% aa drop-out mix (2LEU; 2URA)] and grown
or 3 days at 25°C. After 3 days, 4 independent transfor-
ants from each transfection experiment were plated
nto YNB-glucose minimal medium plates and grown for
additional days at 25°C. Thereafter, replica (ACCUT-
AN replica plater; Schleicher & Schuell) were prepared
nto either YNB-(1)-galactose [containing 3% galactose,
% raffinose, 2% glycerin, 0.5% (NH4)2SO4, 0.17% YNB, 3%
gar, and 0.068% aa drop-out mix (2LEU; 2URA)] or
NB-(2)-galactose plates lacking galactose. Plates were
ncubated at the selective temperature of 36°C for 2
ays.
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